Literature DB >> 16100564

In vitro contractile activity of porcine myometrium during luteolysis and early pregnancy: effect of oxytocin and progesterone.

Beata Kurowicka1, Anita Franczak, Agnieszka Oponowicz, Genowefa Kotwica.   

Abstract

The present study was undertaken to elucidate the role of OT in myometrial contractility in sows. Spontaneous and OT-stimulated contractions of the inner circular (CM) and outer longitudinal (LM) layers isolated from cyclic (Days 14-16) and early pregnant (Days 14-16) sows were examined in six cyclic and six pregnant sows. In addition, the role of P(4) in the modulation of OT-induced uterine contractions was investigated. The contractile activity of the LM and CM layers was recorded in a tissue chamber filled with Krebs-Ringer solution. Myometrial contractility was expressed as area under the contractility curve (AUC) and frequency of contractions. Myometrial longitudinal and circular muscles exhibited spontaneous contractility in sows during both luteolysis and early-pregnancy. The mean AUC was higher (p<0.05) in the LM layer compared to the CM layer in both cyclic and pregnant animals. In addition, pregnant sows were characterized by higher AUC in both LM and CM layers in comparison to cyclic sows. The CM layer was unresponsive to examined treatments. Oxytocin (1-3x10(-8) and 1-3x10(-7)M) increased the AUC and frequency of contractions of the LM layer in both examined animal groups, being more effective during luteolysis (p<0.001) than early pregnancy (p<0.01). Response of the LM layer to OT appeared to be clearly related to the initial spontaneous level of contractility. This response to OT was inhibited (p<0.05) in the presence of OT antagonist (10(-6)M). Moreover, in pregnant sows, OT-stimulated contractile activity of myometrium was inhibited (p<0.05) by P(4) (10(-5)M). In conclusion, OT receptors present in myometrial cells (especially in the LM layer) are involved in the regulation of contractile activity of porcine myometrium during luteolysis and early-pregnancy. In addition, progesterone appears to be involved in this regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100564

Source DB:  PubMed          Journal:  Reprod Biol        ISSN: 1642-431X            Impact factor:   2.376


  7 in total

1.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

2.  Relative transcript abundance of oxytocin receptor gene in porcine uterus during luteolysis and early pregnancy.

Authors:  Agnieszka Oponowicz; Anita Franczak; Beata Kurowicka; Genowefa Kotwica
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

3.  In vivo and in vitro effects of Bidens pilosa L. (Asteraceae) leaf aqueous and ethanol extracts on primed-oestrogenized rat uterine muscle.

Authors:  Longo Frida; Silvíre Rakotonirina; Alice Rakotonirina; Jean-Pierre Savineau
Journal:  Afr J Tradit Complement Altern Med       Date:  2007-10-27

4.  Uterine contractile effects of the aqueous and ethanol leaf extracts of Newbouldia Laevis (Bignoniaceae) in vitro.

Authors:  E Bafor; U Sanni
Journal:  Indian J Pharm Sci       Date:  2009-03       Impact factor: 0.975

Review 5.  Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility.

Authors:  Khaleque N Khan; Akira Fujishita; Taisuke Mori
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

6.  Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors.

Authors:  Agnieszka Blitek; Mateusz Luba; Magdalena Szymanska
Journal:  Animals (Basel)       Date:  2022-08-30       Impact factor: 3.231

7.  Comparison of the porcine uterine smooth muscle contractility on days 12-14 of the estrous cycle and pregnancy.

Authors:  Włodzimierz Markiewicz; Marek Bogacki; Michał Blitek; Jerzy Jan Jaroszewski
Journal:  Acta Vet Scand       Date:  2016-03-22       Impact factor: 1.695

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.